| Date | Title | Description |
| 31.01.2022 | Living Cell Technologies : Quarterly Activity Report and Appendix 4C | Living Cell Technologies Limited
ACN: 104 028 042
ASX: LCT
OTCQB: LVCLY
ASX ANNOUNCEMENT
Appendix 4C Quarterly Activities report for the quarter ended 31 December 2021
December Quarter Highlights
Funding secured for third clinical trial of ... |
| 23.11.2021 | Living Cell Technologies : Non-Renounceable Rights Issue Opens | For personal use only
Living Cell Technologies Limited
ACN: 104 028 042
ASX: LCT
OTCQX: LVCLY
ASX ANNOUNCEMENT
Non-Renounceable Rights Issue Opens
Sydney, Australia & Auckland, New Zealand, 23 November 2021 - Living Cell Technologies (A... |
| 15.11.2021 | Living Cell Technologies : Prospectus- Rights Issue | For personal use only
Rights Issue Prospectus
For personal use only
LIVING CELL TECHNOLOGIES LIMITED
(ACN 104 028 042)
Rights Issue Prospectus
For a pro rata, renounceable rights issue of 2 New Shares for every 3 Shares held at the Record D... |
| 11.11.2021 | CEO's presentation to the AGM 2021 | CEO Presentation to AGM
Professor Bernard Tuch
11 November 2021
www.lctglobal.com
ASX:LCT | OTCQB: LVCLY | www.lctglobal.com | LCTglobal
Safe Harbour Statement
This document contains certain forward-looking statements, relating to LCT's bus... |
| 12.06.2017 | Brain cells from pigs might help treat Parkinson’s patients | Pig brain cells could be the key to treating people with Parkinson’s disease, according to early trials of a promising new treatment that implants the cells into a patient’s brain.
Living Cell Technologies, the company that developed the te... |
| 22.10.2013 | Research analysis finds “little tangible progress toward a cure” for type 1 diabetes | JDCA counts four practical cure approaches currently being developed: islet transplantation; drugs that would stop autoimmune attack and enable cells to regenerate; devices that would reliably replace the function of the pancreas; and cell ... |
| 29.08.2013 | Cell therapy — the missing link for a true artificial pancreas for type 1 diabetes? | As a proposed solution to that, an islet cell transplantation takes islets — clusters of cells that contain beta and other kinds of glucose-regulating cells — from the pancreas of a deceased donor. After being purified and processed, those ... |
| 09.02.2010 | CytoSolv lands $500,000 in seed money | Rhode Island’s state-backed venture arm, the Slater Technology Fund, is investing $500,000 in Providence-based CytoSolv Inc., which is developing a treatment for diabetic ulcers and other wounds.
The company’s technology is based on wound-h... |
| - | Cell therapy — the missing link for a true artificial pancreas for type 1 diabetes? | A closed-loop system of devices referred to as the artificial pancreas has been called the “holy grail” for Type 1 diabetes. Some scientists, though, think the future of diabetes treatment lies not in glucose meters and insulin pumps but in... |
| - | Research analysis finds “little tangible progress toward a cure” for type 1 diabetes | Not nearly enough of the funds donated to the four biggest diabetes non-profits end up in the hands of researchers working on near-term cures for type 1 diabetes, according a new analysis by a research and advocacy group.
“During the past h... |
